The Store Brand Ibuprofen Tablets from Perrigo - B2B pain reliever powering US pharmacy shelves

By Daniel Foster, ad hoc news B2B & Pro Desk. Reviewed July 04, 2026, 9:45 AM ET. Details in the imprint.

Store Brand Ibuprofen Tablets 200 mg from Perrigo are one of those products you notice only when you’re standing under the bright pharmacy lights, reading a small white label on a store-brand bottle next to a better-known national brand. The plastic rattles quietly as a shopper turns it in their hand, comparing dosage, tablet color, and price per pill. That moment of comparison is exactly where Perrigo’s B2B engine hums in the background.

Behind-the-scenes pain relief engine

Perrigo’s store brand ibuprofen 200 mg tablets are sold under dozens of US retail labels, from national chains to regional grocers, all built on the same core formulation and manufacturing backbone. Retailers license their own brand name for the front of the bottle, but the drug facts panel typically traces back to Perrigo as manufacturer. In other words, the product you buy as a supermarket or drugstore store brand often comes from the same production lines that feed multiple banners.

According to Perrigo’s over-the-counter portfolio listings and US Drug Facts documentation, the standard store brand ibuprofen tablets contain 200 mg of ibuprofen per coated tablet, indicated for temporary relief of minor aches and pains such as headache, toothache, backache, menstrual cramps, and muscular aches. The tablets are typically film-coated, off-white to light orange, with a slightly chalky feel if held between fingers, designed to be swallowed with water without a strong aftertaste.

US OTC staple for retailers

Perrigo describes itself as a leading provider of consumer self-care products, emphasizing its role as a manufacturer of store-brand over-the-counter medicines across analgesics, gastrointestinal, and allergy categories. Ibuprofen 200 mg is part of that analgesics core. In the US, chain pharmacies and big-box retailers typically offer equivalent store-brand ibuprofen bottles in sizes ranging from 24 to more than 500 tablets, often merchandised directly next to branded ibuprofen like Advil.

Pricing is the key differentiator: US retailers usually price store-brand ibuprofen 200 mg tablets noticeably below national brands on a per-tablet basis, while marketing equivalent active ingredients and dosage strength. A quick scan of prominent national chains shows store-brand 200 mg ibuprofen bottles of 100 tablets commonly listed in the range of roughly $5 to $9 before promotions, compared with higher price points for branded equivalents, depending on region and retailer. For a budget-conscious shopper considering a long-term arthritis regimen, the math adds up quickly.

Formulation, quality and regulation

From a technical standpoint, the store brand ibuprofen tablets Perrigo supplies are governed by the same US Food and Drug Administration (FDA) monograph standards for OTC analgesics that apply to branded products. Each tablet must contain the labeled amount of active ingredient, within tight tolerance ranges, and pass tests for dissolution, stability, and impurity limits under validated manufacturing processes. Dr. Murray Kessler, Perrigo's CEO, has repeatedly framed store-brand self-care medicines as delivering "high-quality, affordable" alternatives within regulatory frameworks that match or exceed national brands.

On the quality assurance side, Perrigo documents in regulatory and quality certifications that facilities producing OTC analgesics operate under current good manufacturing practice (cGMP) rules, subject to regular inspections. Tablets are typically compressed from granulated ibuprofen and excipients, then coated to improve swallowability and protect the active ingredient from moisture. When you pour a few tablets into your palm in a fluorescent-lit kitchen, the smooth coating and consistent size are a consequence of that controlled process.

Retail partnerships and private label strategy

Perrigo's business strategy in OTC store-brand analgesics hinges on multi-retailer partnerships. The company positions itself as the private label supplier behind retailer-branded products across North America and Europe, rather than marketing an "Ibuprofen 200 mg" line under its own name in US retail settings. Large chains often prefer this model because it lets them own the consumer-facing brand while leveraging Perrigo's scale.

In investor presentations, Perrigo breaks out a "Consumer Self-Care Americas" segment that includes store-brand OTC products sold through major retail partners. Although ibuprofen tablets are one small slice of a broader portfolio that spans allergy relief, gastrointestinal remedies, and more, analgesics remain a core traffic driver for pharmacy aisles. Retailers rely on these high-velocity SKUs to anchor their private label health offerings, with Perrigo supplying consistent volume behind the shelf.

Real-world use cases and B2B dynamics

Stand in a US grocery pharmacy aisle on a busy Sunday afternoon and you can watch the B2B model working in real time. A shopper reaches for a store-brand ibuprofen bottle, glances at the drug facts, maybe looks twice at the tiny line indicating "Manufactured by Perrigo." They compare dosage and warnings to a national brand, then choose based on unit price and trust.

From Perrigo's perspective, that choice is a win regardless of retailer logo. The company sells ibuprofen tablets in bulk to its retail partners, who then set final shelf prices and promotional strategy. A chain might run a "buy one, get one 50% off" deal around holidays, driving volume. The underlying tablets originate from Perrigo facilities, turning per-tablet margins into a steady, scaled revenue stream.

Risks, warnings and responsible use

Ibuprofen, whether sold under a national brand or a store label supplied by Perrigo, is classified as a nonsteroidal anti-inflammatory drug (NSAID). The FDA requires prominent warnings about stomach bleeding, heart attack, and stroke risks associated with NSAIDs, especially at high doses or extended use. The Drug Facts box on store-brand ibuprofen includes age restrictions, dosing intervals, and conditions under which a user should stop taking the product and consult a doctor.

For US consumers, the presence of these standardized warnings is one of the clearest signals that store-brand analgesics are regulated under the same framework as their branded competitors. The tablets in a store-brand bottle from Perrigo supply the same type of 200 mg ibuprofen as national brands when used as directed, but the onus remains on the user to follow dosing guidance, avoid combining with other NSAIDs, and take note of personal medical history.

Perrigo context and stock angle

Perrigo Company PLC, headquartered in Ireland with significant US operations, has long positioned itself as a specialist in self-care products and private label OTC medicines. Over-the-counter pain relief, including ibuprofen 200 mg tablets supplied as store brands, fits into a broader strategy of offering affordable alternatives in categories where consumers have recurring needs.

For US investors, store-brand ibuprofen tablets are part of the "quiet" revenue drivers inside Perrigo's Consumer Self-Care Americas segment, contributing to volumes that underpin the cash flows behind Perrigo stock (NYSE: PRGO, ISIN IE00BGH1M568), without being a headline product on their own.

This article was AI-assisted and editorially reviewed. Product information is provided without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Securities trading carries risks up to total loss.

en | IE00BGH1M568 | PERRIGO COMPANY PLC | boerse | 69688875 | bgmi